REDHILL BIOPHARMA LTD
Market Data Charts Historical Prices Statistics Profile Analysis & Rating Disclosures
www.redhillbio.com
LATE CLINICAL-STAGE DEVELOPMENT AND COMMERCIALIZAION OF DRUGS FOR GASTROINTESTINAL DISEASES.
   Issuer No.   
Corporate No.
   Market Cap (23/05/2019)   
   1573   
   514304005   
    766,806 NIS thousands   
   TASE Supersector
   TASE Sector   
   TASE Subsector   
   Indices   
   High-Tech   
   Biomed   
   Biotechnology   
   TA-90, TA-125, TA-Biomed Index, TA Global-BlueTech, TA-AllShare, TA Tech - Elite, TA-Rimon, TA-SME150, TA-Industrials, Additional Indices   
Shares Bonds Convertible Bonds Warrants All Securities
  REDHILL  
 
Symbol:
RDHLDual-Listed Company Market Maker Appointed for Security  
ISIN: IL0011223810
Security Type : Share
 
Tel-Aviv 23/05/2019
 Closing Price (0.01 NIS)
 270.30 
 Change(%) -0.66% 
 Turnover (NIS)
 230,509 
 Trans.
 97 
 Capital Listed for Trading
 283,686,908 
 Market Cap (NIS thousands)
 766,806 
 Base Price
 272.10 
 Opening Price
 268.10 
 High
 274.90 
 Low
 267.40 
 Yield MTD (%) -4.7% 
 Yield YTD (%) 34.0% 
 Foreign Stock Exchange NASDAQ-GM 
 
 
 
Previous Trading Days - REDHIL BIOPHARM
DateClosing Price (0.01 NIS)Adjusted Closing Price*Change (%)Base PriceOpening PriceHighLowTurnover (NIS)
23/05/2019
270.30
270.30
-0.66%
272.10
268.10
274.90
267.40
230,509
22/05/2019
272.10
272.10
1.34%
268.50
272
273.60
271
296,102
   Open in a Separate Window   
* Adjusted to Dividends and Benefits
Company Disclosures - As of date 5/24/2019 - 10:09 AM Financial Statements
5/23/2019 3:01 PM
5/21/2019 1:59 PM
5/16/2019 4:00 PM
5/15/2019 4:10 PM
5/9/2019 2:59 PM
Recent Company Disclosure (Hebrew Only)
Corporate Actions